
    
      This is a "3+3" dose escalation design with 4 pre-defined TKI258 dose levels (200mg, 300mg,
      400mg and 500mg daily with 5 days on and 2 days off schedule) in combination with a fixed
      standard dose of XELOX (Capecitabine and Oxaliplatin) to establish the recommended phase 2
      dose.
    
  